home / stock / vxrt / vxrt news


VXRT News and Press, Vaxart Inc. From 08/06/20

Stock Information

Company Name: Vaxart Inc.
Stock Symbol: VXRT
Market: NASDAQ
Website: vaxart.com

Menu

VXRT VXRT Quote VXRT Short VXRT News VXRT Articles VXRT Message Board
Get VXRT Alerts

News, Short Squeeze, Breakout and More Instantly...

VXRT - Vaxart Announces Second Quarter 2020 Results

Enhanced Leadership – New CEO in Q2 Ample Cash Runway following Financing by Notable Institutional Healthcare Investors SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are ...

VXRT - SQ, NVAX among premarket gainers

Aerpio Pharmaceuticals (NASDAQ: ARPO ) +61%  on announcing a second clinical trial with funding from MTEC. More news on: Aerpio Pharmaceuticals, Inc., Whiting Petroleum Corporation, Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...

VXRT - 3 Small-Cap Coronavirus Stocks That Could Skyrocket

Where can you find the most explosive growth? With small-cap stocks. That's true with nearly any sector. And it's certainly true when it comes to investing in companies focused on fighting COVID-19. There are many small biotechs developing experimental COVID-19 therapies and vaccine candidates....

VXRT - Here's How to Build the Safest But Most Promising Coronavirus Portfolio

Some are true believers in the power of sophisticated mRNA vaccines, some go for exotic viral vectors, and some are tied to the time-tested cocktail of attenuated viral particles. Whatever approach you prefer, it's clear there's likely more than one way to make a coronavirus vaccine.  At p...

VXRT - This Coronavirus Stock Just Got More Attractive: Should You Buy?

Few stocks have performed better than Vaxart (NASDAQ: VXRT) of late. Year to date, shares of this company are up by more than 3,400%. And despite these massive gains, Vaxart's market cap is still just $1.34 billion, a reasonable level for a clinical-stage biotech. Vaxart's efforts to develo...

VXRT - Biotech Bonanza - Second Half Outlook

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...

VXRT - Better Coronavirus Stock: Inovio vs. Vaxart

Some of the biggest winners of 2020 so far have been small biotechs that are developing COVID-19 vaccine candidates. Shares of Inovio Pharmaceuticals (NASDAQ: INO) , for example, have soared well over 500% year to date.  Vaxart (NASDAQ: VXRT) stock is up more than 3,000%. Some invest...

VXRT - RM LAW Announces Investigation of Vaxart, Inc.

BERWYN, Pa. , July 27, 2020 /PRNewswire/ --  RM LAW, P.C.  announces an investigation on behalf of Vaxart, Inc. ("Vaxart" or the "Company") (NASDAQ: VXRT) investors concerning the Company and its officers' possible violations of federal securities laws. If you purc...

VXRT - RIOT, SOGO, NAK and VXRT among midday movers

Gainers: Wilhelmina International (NASDAQ: WHLM ) +192% . More news on: Wilhelmina International, Inc., Socket Mobile, Inc., MediciNova, Inc., Stocks on the move, , Read more ...

VXRT - HAS, IBN among premarket losers

WISeKey International WKEY  -20% . More news on: Vaxart, Inc., PolarityTE, Inc., Sunworks, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10